| For: | Jakab SS, West AB, Meighan DM, Jr RSB, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol 2007; 13(45): 6087-6089 [DOI: 10.3748/wjg.v13.i45.6087] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i45/6087.htm |
| Number | Citing Articles |
| 1 |
Soraya Salas-Silva, Arturo Simoni-Nieves, Jocelyn Lopez-Ramirez, Leticia Bucio, Luis E. Gómez-Quiroz, María Concepción Gutiérrez-Ruiz, Marcelo G. Roma. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies. Life Sciences 2019; 218: 324 doi: 10.1016/j.lfs.2018.12.044
|
| 2 |
CM Hall, S Glaser, G Alpini. Comprehensive Toxicology. 2018; : 52 doi: 10.1016/B978-0-323-95488-4.01004-4
|
| 3 |
Michele Visentin, Daniela Lenggenhager, Zhibo Gai, Gerd A. Kullak-Ublick. Drug-induced bile duct injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1498 doi: 10.1016/j.bbadis.2017.08.033
|
| 4 |
Paul Wasuwanich, Hassan Choudry, Joshua M. So, Sarah Lowry, Wikrom Karnsakul. Vanishing bile duct syndrome after drug-induced liver injury. Clinics and Research in Hepatology and Gastroenterology 2022; 46(9): 102015 doi: 10.1016/j.clinre.2022.102015
|
